Please upgrade your browser.
"Spent the afternoon with two families dealing with kidney cancer. I lost my mom to this disease.. my dad & I were moved by their journey."
An investigational drug targeting all three forms of the vascular endothelial growth factor (VEGF) receptor was more effective against advanced renal cell carcinoma than a current standard agent, researchers found.
If this marker would be clinically validated, the marker could be used to distinguish patients that would benefit from the drug from those that would not, and spare them a futile therapy with possible side effects.
As is typical in any field of scientific endeavor in which major advances have occurred, more questions are raised than answered. It is therefore somewhat ironic that the availability of these therapies has led to a marked curtailment in renal cancer trial enrollment.
A team of scientists from the National University of Singapore's (NUS) Department of Biological Sciences and Mechanobiology Institute have discovered how a drug-lead compound - a compound that is undergoing preclinical trials as a potential drug - can deprive cancer cells of energy and stop them from growing into a tumor.
Winners of the Kidney Cancer Association's contest enjoy luncheon with Hollywood's Denise Richards, who lost her mom to kidney cancer.
Being a heavy snorer can increase one's risk of cancer five-fold, according to research.
The Kidney Cancer Association's medical experts help to evaluate surveys to assure they're legitimate an meet the highest ethical standards. Don't get caught in a scam. We can help.
Most of the time, it wasnt the pain from her chemotherapy treatments that prompted the 11-year-old kidney cancer patients requests it was embarrassment caused by her ill-fitting wig.
Mount Sinai researchers found that 20 percent of 773,233 patients with Stage IV cancer from the National Cancer Database from 2000-2008 did not receive any anticancer treatment.
|NeonCRM by Neon One|